journal cover

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

Arthritis and Rheumatism

Aug 9, 2003

Juan J Gómez-ReinoBiobadaser Group

Download from

Publisher
PubMed

Abstract

The long-term safety of therapeutic agents that neutralize tumor necrosis factor (TNF) is uncertain. Recent evidence based on spontaneous reporting shows an association with active tuberculosis (TB). We undertook this study to determine and describe the long-term safety of 2 of these ag...read more

Mentioned in this Paper

Monoclonal Antibodies
Necrosis
Antirheumatic Drugs, Disease-Modifying
Tumor Necrosis Factor-alpha
Tuberculosis
Biological Products
Tumor Necrosis Factor Receptor
Adverse Event
Rheumatoid Arthritis
Therapeutic Agent
1
178
Paper Details
References
  • References8
  • Citations480
1
  • References8
  • Citations480
12345...

Feeds With Similar Papers

Tuberculosis

Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. Discover the latest research on tuberculosis here.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Tuberculosis (ASM)

Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. Discover the latest research on tuberculosis here.

Immune Tolerance

Immune tolerance happens when the immune system is not responsive to a substance or organism and does not elicit an immune response. This is a normal physiological response for some antigens, especially when detecting self from non-self. This has been a potential area of therapy for some disorders. Here is the latest research on immune tolerance.

© 2020 Meta ULC. All rights reserved

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

Arthritis and Rheumatism

Aug 9, 2003

Juan J Gómez-ReinoBiobadaser Group

PMID: 12905464

DOI: 10.1002/art.11137

Abstract

The long-term safety of therapeutic agents that neutralize tumor necrosis factor (TNF) is uncertain. Recent evidence based on spontaneous reporting shows an association with active tuberculosis (TB). We undertook this study to determine and describe the long-term safety of 2 of these ag...read more

Mentioned in this Paper

Monoclonal Antibodies
Necrosis
Antirheumatic Drugs, Disease-Modifying
Tumor Necrosis Factor-alpha
Tuberculosis
Biological Products
Tumor Necrosis Factor Receptor
Adverse Event
Rheumatoid Arthritis
Therapeutic Agent
1
178

Feeds With Similar Papers

Tuberculosis

Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. Discover the latest research on tuberculosis here.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Related Papers

Arthritis and Rheumatism

Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy

Arthritis and RheumatismFebruary 12, 2004
Frederick WolfeKathy Urbansky
Paper Details
References
  • References8
  • Citations480
1
  • References8
  • Citations480
12345...

Download from

Publisher
PubMed
/papers/treatment-of-rheumatoid-arthritis-with-tumor/12905464